C4X Discovery appoints CSO

Thursday 13 January 2022
Catherine Jane Tralau-Steward
Appointee name
Catherine Jane Tralau-Steward

United Kingdom

C4X Discovery Holdings Plc has appointed Catherine Jane Tralau-Steward as chief scientific officer to help build the company’s drug discovery capacity. Previously, she was head of alliances for Takeda Pharmaceutical Co Ltd where she managed academic alliances for the company in the US, Australia, Japan and Europe. She also helped build drug discovery portfolios in academic settings at Imperial College London, UK and the University of California San Francisco, US. She is the inventor of three granted patents and a non-inventor contributor of many more.

C4X Discovery announced the appointment on 21 December 2021.

Copyright 2022 Evernow Publishing Ltd